RecruitingNot Applicable

Study About Contrast Media

Estonia120 participantsStarted 2023-09-01

Plain-language summary

Patients hospitalized with adhesive small bowel obstruction (SBO) are randomized to 2 study groups at admission after signing an informed consent form. Water-soluble contrast media (CM) will be administered after 4 or after 24 hours of nasogastric- tube decompression.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients 18 years or older * Adhesive small bowel obstruction diagnosed (clinical, laboratory and radiologic evaluation * No peritonitis present, no need for an emergent surgery * Patients sign an informed consent Exclusion Criteria: * Patients younger than 18 yeas * Patients with mechanical small bowel obstruction caused by incarcerated hernias * Patients with mechanical small bowel obstruction caused by carcinomatosis * Patients with paralytic small bowel obstruction * Patients who have undergone surgery within 6 weeks * Patients who do not want to be enrolled in the study

What they're measuring

SBO resolution

Timeframe: Period of hospitalization- approximately 5 days

Trial details

NCT IDNCT05678023

SponsorUniversity of Tartu

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-30

Contact for this trial

Liis Jaanimäe, MD

+3725224012 liis.jaanimae@kliinikum.ee

View on ClinicalTrials.gov More Small Bowel Obstruction trials